Patents Assigned to SINOXA PHARMA UG
  • Lisuride, Terguride and Derivatives Thereof for Use in the Prophylaxis and/or Treatment of Fibrotic Changes
    Publication number: 20140058108
    Abstract: The present invention relates to the use of 5-HT2 receptor antagonists and in particular of 8-?-ergolines such as lisuride, terguride and the derivatives thereof as 5-HT2B and 5-HT2A receptor antagonists and antioxidants in preferably higher-dosed and preferably continuous use for the treatment, progression prophylaxis and general prophylaxis of organ fibroses and other pathological organ remodeling caused by mesenchymal proliferation
    Type: Application
    Filed: November 4, 2011
    Publication date: February 27, 2014
    Applicant: SINOXA PHARMA UG
    Inventors: Reinhard Horowski, Heinz Palla, Johannes Tack